Identifying patients at risk from nonalcoholic fatty liver-related hepatocellular carcinomas.
作者信息
Sayiner Mehmet, Younossi Zobair M
机构信息
Betty & Guy Beatty Center for Integrated Research, Inova Health System, Falls Church, VA, USA.
Center For Liver Disease, Department of Medicine, Inova Fairfax Hospital, Falls Church, VA, USA.
出版信息
Hepat Oncol. 2016 Apr;3(2):101-103. doi: 10.2217/hep-2016-0002. Epub 2016 Mar 23.
Abstract
摘要
相似文献
1
Identifying patients at risk from nonalcoholic fatty liver-related hepatocellular carcinomas.识别非酒精性脂肪性肝病相关肝细胞癌的高危患者。
Hepat Oncol. 2016 Apr;3(2):101-103. doi: 10.2217/hep-2016-0002. Epub 2016 Mar 23.
2
Hepatocellular Carcinoma Screening and Nonalcoholic Fatty Liver Disease: How is it Different?肝细胞癌筛查与非酒精性脂肪性肝病：二者有何不同？
J Clin Exp Hepatol. 2020 Sep-Oct;10(5):518-524. doi: 10.1016/j.jceh.2020.04.004. Epub 2020 Apr 18.
3
[An interpretation of the AASLD practice guideline on the diagnosis and management of nonalcoholic fatty liver disease in 2017].[2017年美国肝病研究学会非酒精性脂肪性肝病诊断和管理实践指南解读]
Zhonghua Gan Zang Bing Za Zhi. 2017 Sep 20;25(9):687-694. doi: 10.3760/cma.j.issn.1007-3418.2017.09.008.
4
Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.非酒精性脂肪性肝病/非酒精性脂肪性肝炎的组织病理学
World J Gastroenterol. 2014 Nov 14;20(42):15539-48. doi: 10.3748/wjg.v20.i42.15539.
5
Bioinformatics analysis reveals novel core genes associated with nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.生物信息学分析揭示了与非酒精性脂肪性肝病和非酒精性脂肪性肝炎相关的新核心基因。
Gene. 2020 Jun 5;742:144549. doi: 10.1016/j.gene.2020.144549. Epub 2020 Mar 14.
6
Hepatocellular Carcinoma in the Setting of Non-cirrhotic Nonalcoholic Fatty Liver Disease and the Metabolic Syndrome: US Experience.非肝硬化非酒精性脂肪性肝病和代谢综合征背景下的肝细胞癌：美国的经验
Dig Dis Sci. 2015 Oct;60(10):3142-8. doi: 10.1007/s10620-015-3821-7. Epub 2015 Aug 7.
7
[Overview of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis Management].[非酒精性脂肪性肝病/非酒精性脂肪性肝炎管理概述]
Yakugaku Zasshi. 2019;139(9):1147-1153. doi: 10.1248/yakushi.19-00011-1.
8
The Current View of Nonalcoholic Fatty Liver Disease-Related Hepatocellular Carcinoma.非酒精性脂肪性肝病相关肝细胞癌的当前观点
Cancers (Basel). 2021 Jan 29;13(3):516. doi: 10.3390/cancers13030516.
9
Molecular Mechanisms: Connections between Nonalcoholic Fatty Liver Disease, Steatohepatitis and Hepatocellular Carcinoma.分子机制：非酒精性脂肪性肝病、脂肪性肝炎和肝细胞癌之间的联系。
Int J Mol Sci. 2020 Feb 23;21(4):1525. doi: 10.3390/ijms21041525.
10
Animal models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.非酒精性脂肪性肝病/非酒精性脂肪性肝炎的动物模型。
World J Gastroenterol. 2012 May 21;18(19):2300-8. doi: 10.3748/wjg.v18.i19.2300.
引用本文的文献
1
Hepatocellular carcinoma (HCC) in patients with Non-Alcoholic Fatty Liver Disease (NAFLD): screening, treatment and survival analysis in a Brazilian series.巴西系列研究中的非酒精性脂肪性肝病（NAFLD）患者的肝细胞癌（HCC）：筛查、治疗和生存分析。
Clinics (Sao Paulo). 2022 Sep 7;77:100097. doi: 10.1016/j.clinsp.2022.100097. eCollection 2022.
2
Nonalcoholic Fatty Liver Disease and Alcoholic Liver Disease are Major Drivers of Liver Mortality in the United States.非酒精性脂肪性肝病和酒精性肝病是美国肝脏死亡率的主要驱动因素。
Hepatol Commun. 2020 Apr 4;4(6):890-903. doi: 10.1002/hep4.1510. eCollection 2020 Jun.
3
Hepatocellular carcinoma and non-alcoholic fatty liver disease.肝细胞癌与非酒精性脂肪性肝病。
Hepatol Int. 2019 Nov;13(6):688-694. doi: 10.1007/s12072-019-09995-8. Epub 2019 Nov 7.
本文引用的文献
1
Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes.全球非酒精性脂肪性肝病流行病学——患病率、发病率和结局的荟萃分析评估。
Hepatology. 2016 Jul;64(1):73-84. doi: 10.1002/hep.28431. Epub 2016 Feb 22.
2
Hepatocellular carcinoma in cirrhotic versus noncirrhotic livers: results from a large cohort in the Netherlands.肝硬化肝脏与非肝硬化肝脏中的肝细胞癌：来自荷兰一个大型队列的结果。
Eur J Gastroenterol Hepatol. 2016 Mar;28(3):352-9. doi: 10.1097/MEG.0000000000000527.
3
Clinical patterns of hepatocellular carcinoma in nonalcoholic fatty liver disease: A multicenter prospective study.非酒精性脂肪性肝病相关肝细胞癌的临床特征：一项多中心前瞻性研究。
Hepatology. 2016 Mar;63(3):827-38. doi: 10.1002/hep.28368. Epub 2016 Jan 14.
4
Current complications and challenges in nonalcoholic steatohepatitis screening and diagnosis.非酒精性脂肪性肝炎筛查与诊断中的当前并发症及挑战
Expert Rev Gastroenterol Hepatol. 2016;10(1):63-71. doi: 10.1586/17474124.2016.1099433. Epub 2015 Oct 15.
5
Nonalcoholic Fatty Liver Disease-Related Hepatocellular Carcinoma: A Problem of Growing Magnitude.非酒精性脂肪性肝病相关肝细胞癌：一个日益严重的问题。
Semin Liver Dis. 2015 Aug;35(3):304-17. doi: 10.1055/s-0035-1562949. Epub 2015 Sep 17.
6
Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009.2004 年至 2009 年美国非酒精性脂肪性肝病（NAFLD）与肝细胞癌（HCC）的相关性。
Hepatology. 2015 Dec;62(6):1723-30. doi: 10.1002/hep.28123. Epub 2015 Oct 24.
7
Non-alcoholic fatty liver disease-related hepatocellular carcinoma: a sleeping tiger in the Asia Pacific.非酒精性脂肪性肝病相关肝细胞癌：亚太地区的一只沉睡老虎。
Hepatol Int. 2013 Dec;7 Suppl 2:823-32. doi: 10.1007/s12072-013-9453-0. Epub 2013 Jul 31.
8
Epidemiology and Natural History of Non-alcoholic Fatty Liver Disease.非酒精性脂肪性肝病的流行病学与自然史
J Clin Exp Hepatol. 2012 Jun;2(2):135-44. doi: 10.1016/S0973-6883(12)60102-9. Epub 2012 Jul 21.
9
Hepatocellular carcinoma in nonalcoholic fatty liver: role of environmental and genetic factors.非酒精性脂肪性肝病中的肝细胞癌：环境与遗传因素的作用
World J Gastroenterol. 2014 Sep 28;20(36):12945-55. doi: 10.3748/wjg.v20.i36.12945.
10
Temporal trends of nonalcoholic fatty liver disease-related hepatocellular carcinoma in the veteran affairs population.退伍军人事务人群中与非酒精性脂肪性肝病相关的肝细胞癌的时间趋势。
Clin Gastroenterol Hepatol. 2015 Mar;13(3):594-601.e1. doi: 10.1016/j.cgh.2014.08.013. Epub 2014 Aug 19.
Zotero 插件